Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large BCell Lymphoma: A Real World Analysis from 21 US Centers Ayers, E., Zelikson, V., Gurumurthi, A., Sawalha, Y., Annunzio, K., Saha, A., Dong, N., Qualls, D., Amoozgar, B., Kahl, B. S., Baird, J. H., Challa, P., Huntington, S. F., Santos, J., Bair, S. M., Narkhede, M. S., Li, S., Frosch, Z. K., Ho, C. I., Smith, S. D., Winter, A., Landsburg, D. J., Furqan, F., Hamadani, M., Baird, K., Romancik, J. T., Alharthy, H., Law, J., Bojanini, L., Advani, R. H., Hu, B., Johnson, P., Grover, N. S., Kundu, D., Merrill, M., Crombie, J. L., Shafagati, N., Sterling, C., Nastoupil, L. J., Epperla, N. AMER SOC HEMATOLOGY. 2023

View details for DOI 10.1182/blood-2023-174257

View details for Web of Science ID 001159306701069